Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Journal of Gastroenterology and Hepatology, 35(2), 80-85
Lewis, J
9 The consensus statement from the American Association of Clinical Endocrinologists supports the use of GLP-1 RAs as first-line therapy in managing hyperglycaemia in T2D patients with established (or at high risk of) atherosclerotic CVD, as well as in those with chronic kidney disease or a history of stroke or transient ischaemic attack, while recommending the administration of sodiumglucose cotransporter 2 inhibitors to HF patients
But after menopause, risks are between 20% and 60% higher among women who are overweight or obese
Xiong et al
US$ 28.65
US$ 26.25
US$ 26.80
.png)
US$ 24.51
US$ 24.42
US$ 20.85
